Citi Pharma Ltd (CPHL)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 58.47 |
|---|---|
| 52-week range | 56.11 – 93.99 |
| Return, 1 month / 3 months | −20.2% / −22.2% |
| Return, 1 year / 3 years | −33.5% / +185.1% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -36.9% |
| Average daily value traded | 72.82M PKR |
| Dividend yield | – |
Market X-Ray price-based
Fair value limited data
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
About the company
Citi Pharma Limited is a pharmaceutical company registered in Bhai Pheru that manufactures and sells pharmaceuticals, medical chemicals and botanical products. Pharmaceuticals are medicines made for treating and preventing illness, while botanical products are preparations derived from plants and used for health purposes. The company's work spans the making of these medicines and chemicals as well as their sale to the market.
On this site Citi Pharma Ltd appears as a stock on the Pakistan Stock Exchange (PSX), code CPHL, with prices in Pakistani rupees (PKR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Citi Pharma Ltd (CPHL) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 58.47 on 27 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 348 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.5% and over the last three months it fell 22.2%. Returns are price returns, dividends not included.
Our limited-data fair value is PKR 72.66 (Undervalued, +24.3% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.2% | ||
| From 52-week high | -36.6% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -22.2% | ||
| 6-month return | -26.3% | ||
| 12-month return, skipping the last month | -16.6% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.9% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 72.82M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −20.2% |
| 3 months | −22.2% |
| 6 months | −26.3% |
| 1 year | −33.5% |
| 3 years | +185.1% |
| 5 years | +119.8% |
Signals
| 50-day / 200-day average | 69.75 / 77.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Oct 2025 | PKR 3.5000 |
| 17 Oct 2024 | PKR 3.2500 |
| 25 Oct 2023 | PKR 2.5000 |
| 18 Oct 2023 | PKR 2.5000 |
| 18 Oct 2021 | PKR 1.6500 |
Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built
| P/E multiple | PKR 71.83 |
|---|---|
| P/S multiple | PKR 74.08 |
| P/E on average earnings | PKR 72.08 |
How to read this report
Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.